CH Chartres
About CH Chartres
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
GERCOR - Multidisciplinary Oncology Cooperative Group
11
Intergroupe Francophone de Cancerologie Thoracique
9
Nantes University Hospital
6
Centre Hospitalier Departemental Vendee
4
Amgen
3
Biotronik SE & Co. KG
3
Centre Hospitalier of Chartres
3
Federation Francophone de Cancerologie Digestive
3
Hospices Civils de Lyon
3
Intergroupe Francophone du Myelome
3
MicroPort CRM
3
Clinical Trials at CH Chartres
During the past decade, CH Chartres conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 7 clinical trials were completed, i.e. on
average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 5 clinical trials were completed. i.e. 27.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer
1995-02-01
Completed
3,300
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1998-10-01
Active, not recruiting
1,649
Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer
2000-05-01
Unknown status
Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer
2000-10-01
Unknown status
Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct
1999-01-01
Unknown status
Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma
2003-11-01
Unknown status
Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach
2001-04-01
Unknown status
Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer
2002-06-01
Unknown status
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CH Chartres" #1 sponsor was "GERCOR - Multidisciplinary Oncology Cooperative Group" with 11 trials, followed by "Intergroupe Francophone de Cancerologie Thoracique" with 9 trials
sponsored, "Nantes University Hospital" with 6 trials sponsored, "Centre Hospitalier Departemental Vendee" with 4 trials sponsored and "Amgen"
with 4 trials sponsored. Other sponsors include 70 different institutions and
companies that sponsored additional 52 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CH Chartres"
#1 collaborator was "University Hospital, Tours" with 4 trials as a collaborator, "Ministry of Health, France" with 3 trials as a collaborator, "University Hospital, Caen" with 3 trials as a collaborator, "University Hospital, Clermont-Ferrand" with 3 trials as a collaborator and "Assistance Publique Hopitaux De Marseille" with 2 trials as a collaborator. Other collaborators include 83 different institutions and companies that were
collaborators in the rest 82 trials.
Clinical Trials Conditions at CH Chartres
According to Clinical.Site data, the most researched conditions in "CH Chartres" are
"Critical Illness" (5 trials), "Pancreatic Cancer" (5 trials), "Colorectal Cancer" (4 trials), "Lung Cancer" (4 trials) and "Multiple Myeloma" (4 trials). Many other conditions were trialed in "CH Chartres" in a lesser frequency.
Clinical Trials Intervention Types at CH Chartres
Most popular intervention types in "CH Chartres" are "Drug" (52 trials), "Other" (26 trials), "Device" (15 trials), "Procedure" (11 trials) and "Radiation" (9 trials). Other intervention types were less common.
The name of intervention was led by "radiation therapy" (7 trials), "Placebo" (5 trials), "gemcitabine hydrochloride" (4 trials), "oxaliplatin" (4 trials) and "fluorouracil" (3 trials). Other intervention names were less common.
Clinical Trials Genders at CH Chartres
The vast majority of trials in "CH Chartres" are
99 trials for "All" genders and 9 trials for "Female" genders.
Clinical Trials Status at CH Chartres
Currently, there are NaN active trials in "CH Chartres".
undefined are not yet recruiting,
22 are recruiting,
7 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 54 completed trials in CH Chartres,
undefined suspended trials,
and 9 terminated clinical trials to date.
Out of the total trials that were conducted in CH Chartres, 0 "Phase 1"
clinical trials were conducted, 15 "Phase 2" clinical
trials and 39 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 21 trials that are defined as “Not Applicable".
Departments of CH Chartres
CH Chartres has several departments that took part in Clinical trials: "Hopital Louis Pasteur; Oncologie Hematologie" - 2 trials
Departments List
Name
City
Trials